{'52WeekChange': None,
 'SandP52WeekChange': None,
 'address1': '500 Arsenal Street',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 48.14,
 'askSize': 800,
 'averageDailyVolume10Day': 123887,
 'averageVolume': 156922,
 'averageVolume10days': 123887,
 'beta': 0.539495,
 'beta3Year': None,
 'bid': 24.44,
 'bidSize': 1800,
 'bookValue': 24.317,
 'category': None,
 'circulatingSupply': None,
 'city': 'Watertown',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 49.03,
 'dayLow': 47.365,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': 41.881,
 'enterpriseToRevenue': 3.519,
 'enterpriseValue': 618872064,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '617-607-0530',
 'fiftyDayAverage': 50.54286,
 'fiftyTwoWeekHigh': 78.42,
 'fiftyTwoWeekLow': 38.4,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 16102227,
 'forwardEps': -2.63,
 'forwardPE': -18.311787,
 'fromCurrency': None,
 'fullTimeEmployees': 132,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.11537,
 'heldPercentInstitutions': 0.92196,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1569801600,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/enanta.com',
 'longBusinessSummary': 'Enanta Pharmaceuticals, Inc., a biotechnology '
                        'company, focuses on the research and development of '
                        'small molecule drugs for the treatment of viral '
                        'infections and liver diseases. Its research and '
                        'development disease targets include respiratory '
                        'syncytial virus, non-alcoholic steatohepatitis, '
                        'primary biliary cholangitis, and hepatitis B virus. '
                        'Enanta Pharmaceuticals, Inc. has a collaborative '
                        'development and license agreement with Abbott '
                        'Laboratories to identify, develop, and commercialize '
                        'HCV NS3 and NS3/4A protease inhibitor compounds, '
                        'including paritaprevir and glecaprevir for the '
                        'treatment of chronic hepatitis C virus. The company '
                        'was founded in 1995 and is headquartered in '
                        'Watertown, Massachusetts.',
 'longName': 'Enanta Pharmaceuticals, Inc.',
 'market': 'us_market',
 'marketCap': 963407104,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_345286',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': 23665000,
 'nextFiscalYearEnd': 1632960000,
 'open': 48.49,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '617-607-0800',
 'previousClose': 48.82,
 'priceHint': 2,
 'priceToBook': 1.9805075,
 'priceToSalesTrailing12Months': 5.4779816,
 'profitMargins': 0.13456,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 49.03,
 'regularMarketDayLow': 47.365,
 'regularMarketOpen': 48.49,
 'regularMarketPreviousClose': 48.82,
 'regularMarketPrice': 48.49,
 'regularMarketVolume': 133465,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 20004300,
 'sharesPercentSharesOut': 0.093,
 'sharesShort': 1860343,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1604902,
 'shortName': 'Enanta Pharmaceuticals, Inc.',
 'shortPercentOfFloat': 0.113900006,
 'shortRatio': 11.01,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'ENTA',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': 1.134,
 'trailingPE': 42.46914,
 'twoHundredDayAverage': 52.109604,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': '0716474a-69e6-3365-b278-ac9fe128aaa5',
 'volume': 133465,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.enanta.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '02472'}